-
Product Insights
Aby-Alebo Wind Project
Aby-Alebo Wind Project is an Onshore Wind project located in Kalmar, Sweden. The project is owned by SR Energy AB and was developed by SR Energy AB; Statkraft AS. The project came online in 2021. Empower your strategies with our Aby-Alebo Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABI-2280 in Cervical Intraepithelial Neoplasia (CIN)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABI-2280 in Cervical Intraepithelial Neoplasia (CIN) report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Saroglitazar in Liver Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Saroglitazar in Liver Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Saroglitazar in Liver Diseases Drug Details: Saroglitazar (lipaglyn) is the first...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tagraxofusp in Hypereosinophilic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tagraxofusp in Hypereosinophilic Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tagraxofusp in Hypereosinophilic Syndrome Drug Details: Tagraxofusp (Elzonris) acts as an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Paclitaxel Albumin Bound in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel Albumin Bound in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel Albumin Bound in Adenocarcinoma Of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Paclitaxel Albumin Bound in Metastatic Transitional (Urothelial) Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel Albumin Bound in Metastatic Transitional (Urothelial) Tract Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel Albumin Bound in Metastatic Transitional (Urothelial)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olaparib in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olaparib in Oropharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olaparib in Oropharyngeal Cancer Drug Details: Olaparib (Lynparza) is an antineoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olaparib in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olaparib in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olaparib in Adenocarcinoma Of The Gastroesophageal Junction Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Izokibep in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Izokibep in Hidradenitis Suppurativa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Izokibep in Hidradenitis Suppurativa Drug Details: Izokibep (ABY-035) is under development for...